Aussie's IDT to manufacture 23 generic drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Apr, 2015

Singapore: US FDA has accepted the transfer of ownership of 23 generic drug products to Australia based IDT. Formalising change of ownership is a process whereby the vendor and the purchase...Read more

Novartis case hearing against Indian patent office on Sept 11

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2012

Bangalore: The Supreme Court will take up the landmark case involving swiss drugmaker Novartis and India's patent office on September 11, 2011. The case was due to come up for hearing on Au...Read more

Generics will lead to $7 bn loss for statins market

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jan, 2013

Singapore: GBI Research has highlighted that the introduction of generic statins has kick started a decline in the global statins market and this is expected to lead to a loss of over $7 bi...Read more

Sun Pharma's founder named India's 3rd richest

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Oct, 2013

Singapore: For the first time, founder of leading Indian drugmaker Sun Pharmaceuticals, Mr Dilip Shanghvi has been named in the top three of India's richest men. Mr Shanghvi has made an ap...Read more

Mylan launches generic of Pfizer's antifungal drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

Singapore: US-based Mylan Pharmaceuticals has launched generic version of Pfizer's Vfend, Voriconazole for Oral Suspension, 40 mg/mL. Mylan was the first company to have filed a substantia...Read more

Cipla wins patent case against Roche

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2012

Bangalore: India's generics giant Cipla has won a landmark patent case against Swiss drug maker Roche in the Delhi High Court. Roche had filed a patent infringement case against Cipla in 20...Read more

Sun Pharma registers Rs 1391 crores profit in Q1

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Aug, 2014

Singapore: Posting a net profit of Rs 1391 crores in Q1, Sun Pharma exhibited a flat growth in line with the market expectations. India's most valued drug maker said that the process of acq...Read more

Teva patent request rejected by US Supreme Court

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Nov, 2013

Singapore: The US Supreme Court declined a request from Teva Pharmaceutical for a stay of an appeals court ruling that would void patent protection for its $4 billion-a-year multiple sclero...Read more

Daiichi Sankyo seeks approval for TB drug in Japan

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 06 Oct, 2014

Singapore: Daiichi Sankyo's generic subsidiary, Daiichi Sankyo Espha has submitted a supplemental New Drug Application (sNDA) seeking approval for its synthetic broad-spectrum oral antibact...Read more

Aurobindo to acquire Actavis generics unit in EU

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Jan, 2014

Mumbai: India-based Aurobindo Pharma intends to acquire Actavis' generics commercial operations in seven markets in Western Europe. The transaction is conditional on certain antitrust appro...Read more

Ranbaxy sues Actavis to stop acne generic sale

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Nov, 2013

Singapore: Dublin headquartered generic drugmaker Actavis has now been caught in a legal tangle after Indian drug major Ranbaxy Laboratories filed a legal case against the company. Ranbaxy...Read more

IPAB revokes patent for GSK's anti-cancer drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

New Delhi: In yet another blow to multinational companies operating in India, the Intellectual Property Appellate Board (IPAB) has revoked the patent for UK drug maker GlaxoSmithKline's GSK...Read more

TWi appoints new CEO to boost US market

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Mar, 2015

Singapore: Taiwan based TWi Pharmaceuticals has appointed Ms Tina Guilder as President and CEO and Ms Eva Ho as CFO to step up the US operation. TWi Pharmaceuticals announced that Ms Guild...Read more

German firm buys $200 mn stake in Indian generic company

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 28 Nov, 2013

Singapore: Gland Pharma, a leading Indian pure-play generic injectable pharmaceutical products company, has signed an agreement under which KKR, a global investment firm, will acquire a min...Read more

Biocon: A nesting ground for biotech spinoffs

Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 16 May, 2014

It has added one more feather to its cap by being the nesting ground to churn out new start-ups. It is an informal incubation lab for new spinoffs. Biocon, without any hesitance, is the mo...Read more

FAPA: Indian pharma to fatten in biosimilars era

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Aug, 2014

Singapore: The Federation of Asian Pharmaceuticals Association (FAPA) said that the upcoming patent cliff will be advantageous for the Indian drug makers as biosimilars are all set to make ...Read more

Celltrion files an FDA application for biosimilar

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Aug, 2014

Singapore: With biosimilars promising an exponential growth, South Korea's Celltrion has filed an FDA application for Remisma, a biosilmilar of Johnson & Johnson's (J&J) blockbuster...Read more

Wockhardt's third Indian plant faces export ban

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 23 Oct, 2013

Singapore: Britain's drug regulator, the UK Medicines and Healthcare Products Regulatory Agency has revoked the quality compliance certificate provided to Wockhardt's third unit in India. ...Read more